Q2 2026 Holdings
Filed 2026-08-14 | 53 holdings | $164.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $29.7M | 88,781 | 18.1% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $17.7M | 492,893 | 10.8% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $17.0M | 512,160 | 10.4% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $11.2M | 1,085,000 | 6.8% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $10.9M | 2,844,652 | 6.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $8.7M | 65,630 | 5.3% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $8.0M | 549,985 | 4.9% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $6.9M | 700,000 | 4.2% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $6.7M | 827,500 | 4.1% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $6.0M | 451,255 | 3.7% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $6.0M | 324,452 | 3.7% |
| Xencor Inc(XNCR) | COM | 98401F105 | $4.1M | 255,000 | 2.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.9M | 750,000 | 2.4% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $3.7M | 8,753,290 | 2.3% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $2.9M | 471,559 | 1.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $2.7M | 570,000 | 1.6% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $2.3M | 352,000 | 1.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $2.1M | 250,000 | 1.3% |
| Rein Therapeutics Inc(RNTX) | COM NEW | 00887A204 | $1.8M | 1,700,000 | 1.1% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $1.5M | 105,000 | 0.9% |
| Nasus Pharma LTD | ORD SHS | M7071P109 | $1.3M | 359,390 | 0.8% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $1.1M | 170,278 | 0.7% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $1.1M | 2,668,395 | 0.7% |
| Tenax Therapeutics Inc(TENX)Call | COM NEW | 88032L605 | $999.6K | 68,700 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $453.5K | 3,700 | 0.3% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $450.0K | 120,000 | 0.3% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $391.0K | 230,000 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $388.2K | 16,000 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $349.7K | 130,000 | 0.2% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $314.4K | 40,000 | 0.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $296.8K | 11,000 | 0.2% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $277.2K | 60,000 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $243.9K | 26,000 | 0.1% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $242.5K | 25,000 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $221.4K | 20,000 | 0.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $218.6K | 10,000 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $211.9K | 10,000 | 0.1% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $206.3K | 6,000 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $205.2K | 60,000 | 0.1% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $195.4K | 20,000 | 0.1% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $193.6K | 40,000 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $183.7K | 10,000 | 0.1% |
| Scynexis Inc(SCYX) | COM | 811292309 | $162.8K | 40,000 | 0.1% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $156.7K | 32,372 | 0.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T209 | $136.9K | 14,285 | 0.1% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $103.7K | 148,138 | 0.1% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $101.8K | 25,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $100.7K | 33,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $83.7K | 45,000 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $33.1K | 59,700 | 0.0% |